Dopamine is implicated in movement, learning, and motivation, and in illnesses such as Parkinson's disease, schizophrenia, and drug addiction. Little is known about the control of dopamine release in humans, but research in experimental animals suggests that the prefrontal cortex plays an important role in regulating the release of dopamine in subcortical structures. Here we used [
Animal experiments have shown that descending pathways from the frontal cortex modulate the release of dopamine in subcortical areas such as the striatum (Murase et al., 1993; Fibiger, 1993, 1995; Karreman and Moghaddam, 1996) . There is evidence that, in the rat, this occurs both directly, via glutamatergic corticostriatal projections , and indirectly by an effect on mesostriatal dopamine neurons in the midbrain (Murase et al., 1993; Karreman and Moghaddam, 1996) . This modulation may be relevant to the pathophysiology of disorders associated with subcortical dopamine dysfunction such as Parkinson's disease (Kish et al., 1988) , schizophrenia (Grace, 1991) , and depression (Willner, 1983) . Little is known, however, about the anatomical pathways involved in the control of dopamine release in humans. Previous studies (Fox et al., 1997; Paus et al., 1997 Paus et al., , 1998 Siebner et al., 1998) have shown that functional brain imaging can be used to measure changes in cerebral blood flow and glucose metabolism induced by transcranial magnetic stimulation. The aim of the present study was to use positron emission tomography (PET) to determine whether repetitive transcranial magnetic stimulation (rTMS) of the left mid-dorsolateral prefrontal cortex (MDL-PFC) induces dopamine release in the striatum of the human brain.
We used the dopamine receptor ligand [ 11 C]raclopride to detect changes in levels of extracellular dopamine after rTMS. In vivo binding of benzamide tracers such as [
11 C]raclopride has been shown to be inversely proportional to levels of extracellular dopamine (Endres et al., 1997; Laruelle et al., 1997) . In humans, this method has been used to measure dopamine release in response to drugs (Dewey et al., 1993; Smith et al., 1997; Volkow et al., 1997; Breier et al., 1998) and behavioral tasks (Koepp et al., 1998) . We now report results from eight healthy volunteers who underwent two [
11 C]raclopride PET scans, one immediately after rTMS of the left MDL-PFC and one after rTMS of the left occipital cortex for control purposes. Statistical parametric maps representing the change in [
11 C]raclopride binding potential (BP) were generated to infer changes in the levels of extracellular dopamine (Aston et al., 2000) .
MATERIALS AND METHODS
E xperimental design. Five female and three male healthy volunteers (ages, 19 -42 years) participated in the study after having given written informed consent. All subjects but one were right-handed, and none had a history of neurological or psychiatric illness. Each underwent two [ 11 C]raclopride PET scans (total injected dose, 20 mC i), one after rTMS of the left MDL -PFC and one after rTMS of the left occipital cortex. The scan order was randomized across subjects, and the scans were always performed at the same time in the afternoon on consecutive days. Autonomic parameters and subjective ratings were collected throughout both sessions of rTMS and PET. During the study, the subjects kept their eyes closed; earplugs were used to attenuate the coil-generated clicks. The experiments were approved by the Research Ethics Committee of the Montreal Neurological Institute and Hospital.
Transcranial magnetic stimulation. Repetitive TMS was performed with the Cadwell high-speed magnetic stimulator (Cadwell Laboratories, Kennewick, WA) using a circular coil (external diameter, 9 cm). The coil was held outside the scanner in a fixed position by a mechanical arm over the left MDL-PFC or the left occipital cortex. It was positioned so that the anterior tip of the coil was closest to the cortical site, with the rest of the coil tilted away from the skull. The induced current under the coil flowed in a lateromedial direction. Three rTMS blocks were delivered, each block separated by a 10 min interval. In each block, 15 10-pulse trains of 1 sec duration were delivered at a stimulation frequency of 10 Hz and with a between-train interval of 10 sec. Thus, a total of 450 stimuli were delivered over a period of 30 min preceding the start of PET acquisition. The stimulus intensities, which were expressed as a percentage of the maximum stimulator output, were set at the resting motor threshold (MT). MT was defined as the lowest stimulus intensity able to elicit, in the right first dorsal interosseous (FDI), five motor-evoked potentials (MEPs) of at least 50 V amplitude in a series of 10 stimuli delivered over the left primary motor cortex at intervals Ͼ5 sec. MEPs were recorded from the right FDI muscle with AgCl surface electrodes that were fixed on the skin with a belly-tendon montage. The EMG signal was filtered (10 Hz-1 kHz bandpass) and displayed on a computer screen. Repetitive TMS at MT over either of the experimental stimulation sites, MDL-PFC and occipital cortex, did not induce EMG activation in the right FDI.
Subjective ratings and autonomic measures. The following autonomic parameters were collected for 2.5 min during a baseline period at the start of the study and during the rest periods after each block of rTMS: electrodermal level, respiration rate, and temperature. After the baseline period and after each rest period, subjects completed a behavioral questionnaire in which they rated the level of their comfort, fatigue, anxiety, mood, irritation, and pain. Ratings were made on a seven-point Likert scale ranging from Ϫ3 to 3, with Ϫ3 indicating the highest negative level and 3 indicating the highest positive level for each dimension. Baseline ratings focused on how subjects were currently feeling, whereas ratings after blocks of rTMS focused on how subjects felt during the preceding rTMS stimulation.
Location of the target site. To target the desired sites in all of our subjects, we used a procedure that takes advantage of the standardized stereotaxic space of Talairach and Tournoux (1988) and frameless stereotaxy (Peters et al., 1996) . A high-resolution magnetic resonance image (MRI) of the subject's brain was acquired and transformed into standardized stereotaxic space (Collins et al., 1994) . The chosen Talairach coordinates of the left MDL -PFC (X ϭ Ϫ40, Y ϭ 32, Z ϭ 30) (Petrides et al., 1993) and left occipital cortex (X ϭ Ϫ56, Y ϭ Ϫ58, Z ϭ Ϫ3) were converted into each subject's native MRI space using the reversed nativeto-Talairach transformation (Paus et al., 1997) . The positioning of the TMS coil over these locations, marked on the native MRI, was performed with the aid of a frameless stereotaxic system (Paus, 1999) .
Positron emission tomography. PET scans were obtained with a C TI / Siemens HR plus tomograph operated in 3-D mode, yielding images of resolution 4.2 mm f ull width at half maximum. Within 5 min of the completion of the rTMS session, 10 mC i of [ 11 C]raclopride was injected into the left antecubital vein over 60 sec, and emission data were acquired over a period of 60 min in 26 frames of progressively increasing duration. After the emission scan, a transmission scan was performed with a rotating radioactive source for attenuation correction.
PET frames were summed, registered to the corresponding MRI (Woods et al., 1993) , and transformed into standardized stereotaxic space (Talairach and Tournoux, 1988) by means of an automated featurematching algorithm (Collins et al., 1994) . Voxel-wise [ 11 C]raclopride BP was calculated using a simplified reference tissue method (Lammertsma and Hume, 1996; Gunn et al., 1997) to generate statistical parametric images of change in BP (Aston et al., 2000) . Only peaks falling within the striatum were considered for f urther analysis, because this is the only brain structure in which receptor-specific [ 11 C]raclopride binding is detected. A reduction in [
11 C]raclopride BP is indicative of an increase in extracellular dopamine concentration (Endres et al., 1997; Laruelle et al., 1997) . In each subject, BP values from the left and right caudate nuclei were extracted with two regions of interest drawn on three adjacent axial sections (z, 4-8 mm) of the subject's MRI in stereotaxic space and confined to the head of the caudate nucleus. These BP values were analyzed using repeated measures ANOVA.
RESULTS

Repetitive TMS of the left MDL-PFC decreased [
11 C]raclopride BP in the left caudate nucleus compared with rTMS of the left occipital cortex (Fig. 1, Table 1 ). This is most likely because of an increase in extracellular dopamine concentration after prefrontal stimulation. Table 1 shows BP values from the left and right caudate nuclei that were derived from a region-of-interest drawn on the MRI of each subject at the level of the statistical peak revealed by the parametric map. Repeated measures ANOVA revealed a significant effect of stimulation site for the left caudate nucleus (F (1,7) ϭ 91.3; p Ͻ 0.0001), but not for the right caudate nucleus (F (1,7) ϭ 0.94; NS). The mean magnitude of change in [
11 C]raclopride BP in the left caudate nucleus was Ϫ7.3%. There was no significant relationship between the intensity of TMS and the change in [ 11 C]raclopride BP. Repetitive TMS of the left MDL-PFC did not lead to a statistically significant change in [ 11 C]raclopride BP in the putamen or the nucleus accumbens. The autonomic measures and replies to the questionnaires were analyzed using repeated measures ANOVA. Because there were no significant differences between the three rTMS periods, data were pooled. ANOVA revealed no significant main effect of site of stimulation (MDL-PFC, occipital) or condition (before and after rTMS) nor any significant site-by-condition interaction (Tables 2, 3).
DISCUSSION
We have shown that rTMS of the left MDL-PFC can evoke release of striatal dopamine in humans, as detected by [ 11 C]raclopride PET. The fact that the BP change was seen only in the ipsilateral head of the caudate nucleus suggests that corticostriatal fibers originating in the MDL-PFC were involved in promoting local dopamine release at their striatal target site. Anatomical studies in rhesus monkeys have shown that the MDL-PFC projects to the dorsal caudate nucleus (Selemon and GoldmanRakic, 1985; Yeterian and Pandya, 1991) . Moreover, corticostriatal fibers originating in the PFC are thought to project only or predominantly to the ipsilateral striatum (Kemp and Powell, 1970) . Thus, the area of statistically significant change in [
11 C]raclopride binding in our study corresponds to the major projection site of corticostriatal fibers originating in the stimulated area in MDL-PFC.
These excitatory corticostriatal projections could promote dopamine release by a local effect of glutamate on adjacent nigrostriatal nerve terminals (Cheramy et al., 1986) . Such an effect may be mediated by ionotropic (Leviel et al., 1990) or metabotropic glutamate receptors in the striatum, perhaps acting on dopamine nerve terminals via nitric oxide (Hanbauer et al., 1992) . The existence of this mechanism is supported by the fact that cortical neurons originating in the PFC and dopamine neurons from the ventral tegmental area synapse in close proximity to one another on the spines of striatal medium spiny neurons (Sesack and Pickel, 1992) .
However, the possibility of indirect modulation of striatal dopamine via corticonigral projections also must be taken in consideration. In rats, stimulation of the PFC can promote bilateral striatal dopamine release by activation of dopamine neurons in the ventral tegmental area (Murase et al., 1993; Karreman and Moghaddam, 1996) . This could occur via direct and indirect connections between the PFC and midbrain dopamine neurons. On the basis of these animal experiments, one would expect that dopamine released by this mechanism would not be confined to one area of the dorsal caudate, but rather that it would involve the neostriatum and nucleus accumbens, possibly bilaterally (Karreman and Moghaddam, 1996) . In this experiment, we did not detect such widespread release of striatal dopamine, suggesting that our results reflect only the action of the Strafella et al.
• Dopamine and Transcranial Magnetic Stimulationdirect corticostriatal projections. Grace (1991) has suggested that dopamine released under direct corticostriatal influence diffuses into the extrasynaptic space, whereas the dopamine that is released because of midbrain dopamine neuron burst firing is rapidly cleared from the synapse by reuptake into the nerve terminal. It is possible that the [ 11 C]raclopride PET technique is most sensitive to extrasynaptic dopamine.
The rTMS-induced release of dopamine in the caudate nucleus could be a consequence of direct stimulation of the corticostriatal axons (Rothwell, 1997) , indirect trans-synaptic activation of corticostriatal neurons caused by a reduction in GABA-mediated intracortical inhibition Nakamura et al., 1997; Rothwell, 1997; Pascual-Leone et al., 1998) , or both.
In conclusion, these results show for the first time the ability of PET to detect in humans changes in levels of extracellular dopamine after rTMS of MDL-PFC. This technique opens up new avenues for in vivo studies of corticostriatal interactions in humans and for clinical studies of neurological and psychiatric disorders associated with subcortical dopamine dysfunction.
